Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Manu
M A
MA
Department of Urology, Tokyo Women's Medical University, Japan.
Tanabe
K
K
Ishikawa
N
N
Tokumoto
T
T
Oshima
T
T
Shinmura
H
H
Harano
M
M
Otsubo
S
S
Inui
M
M
Kanematsu
A
A
Fuchinoue
S
S
Toma
H
H
D000017:ABO Blood-Group System; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005922:Glomerulonephritis, IGA / Q000139:chemically induced*; D006084:Graft Rejection / Q000188:drug therapy*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone